EVP R&D, Operations and Service Marc Nash to depart Outset Medical June 5

Outset Medical, Inc.

Marc Nash resigned as EVP R&D, Operations and Service effective June 5, 2026.
Departure is to pursue other professional opportunities.
Company confirms no dispute or disagreement with Nash or management.
No replacement for Nash has been announced as of the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marc Nash

Executive Vice President, R&D, Operations and Service

OM · Outset Medical, Inc.

Effective: 2026-06-05
Filed: May 29, 2026, 4:05 PM ET

On May 26, 2026, Marc Nash informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as Executive Vice President, R&D, Operations and Service, effective June 5, 2026, to pursue other professional opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc Nash departed as Executive Vice President, R&D, Operations and Service at Outset Medical, Inc..

Action: informed of his decision to depart
Role: Executive Vice President, R&D, Operations and Service

Exact text from the filing

On May 26, 2026, Marc Nash informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as Executive Vice President, R&D, Operations and Service, effective June 5, 2026, to pursue other professional opportunities.

View on SEC.gov

Outset Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-248237

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.